出处
《基础医学与临床》
CSCD
北大核心
2008年第4期391-393,共3页
Basic and Clinical Medicine
基金
河北省科技攻关计划项目(07276101D-73)
参考文献3
-
1Dzurik R. Spustova V. Nitric oxide and tile kidneys[J]. Vnitr Lek, 2001,47(2) :101 -105.
-
2Camici GG, Schiavoni M, Francia P, et al. Genetic deletion of p66 (shc) adaptorprotein prevent hyperglycemia-induced endothelial dysfunction and oxidative stress [ J ].Proc Natl Acad Sci, 2007, 104(12) :5217 -5222.
-
3Wolff DJ, Lubeskie A. Aminoguanidine is an isoform-selectire, mechanism-based inactivator of nitric oxide synthase [J]. Arch Biochem Biophys, 1995, 316(1) : 290 -301.
同被引文献19
-
1詹宇红,赵同峰,邓华聪,赵江佩.阿魏酸钠抑制糖尿病大鼠心肌非酶糖基化的形成[J].基础医学与临床,2005,25(5):455-458. 被引量：6
-
2Goldin A,Beckman JA,Schmidt AM,et al.Advanced glycation end products:sparking the development of diabetic vascular injury.Circulation,2006,114:597-605.
-
3Silan C.The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats.Biol Pharm Bull,2008,31:897-902.
-
4Walcher D,Marx N.Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.Semin Immunopathol,2009,31:103-111.
-
5Yoon SJ,Yoon YW,Lee BK,et al.Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation end products in vascular smooth muscle cells of diabetic vasculopathy.Exp Mol Med,2009,41:802-811.
-
6Zhou YJ,Yang HW,Wang XG,et al.Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells.Life Sci,2009,85:670-677.
-
7Baba SP,Barski OA,Ahmed Y,et al.Reductive metabolism of AGE precursors:a metabolic route for preventing AGE accumulation in cardiovascular tissue.Diabetes,2009,58:2486-2497.
-
8Kitahara Y,Takeuchi M,Miura K,et al.Glyceraldehyde-de-rived advanced glycation end products (AGEs).A novel biomarker of postprandial hyperglycaemia in diabetic rats.Clin Exp Med,2008,8:175-177.
-
9Hirose A,Tanikawa T,Mori H,et al.Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway.FEBS Lett,2010,584,61-66.
-
10Abebe W.Effects of taurine on the reactivity of aortas from diabetic rats.Life Sci,2008,82:279-289.
引证文献2
-
1刘丽媛,张誉洋,王海昌,黄洁,周萱.晚期糖基化终末产物对糖尿病大鼠主动脉结构和功能的影响[J].中华老年心脑血管病杂志,2010,12(5):452-455.
-
2洪霓,赵倩,刘腾,张辉,刘琦,王云,王雯.GLP-1受体激动剂Exenatide改善糖尿病大鼠心血管功能[J].基础医学与临床,2013,33(9):1171-1175. 被引量：1
-
1赵亚刚,张小瑞,吴炜景,谢子英,孟东方.诱导性一氧化氮合酶在幽门螺杆菌与胃癌关系中的研究进展[J].实用医学杂志,2009,25(7):1166-1167. 被引量：4
-
2宋翠荣,张海峰,庞胤,陈俊荣.诱导性一氧化氮合酶在动脉硬化中的作用[J].医学与哲学（B）,2010,31(8):49-50. 被引量：3
-
3陈智龙,吕永慧,王玎,涂星.清热化湿舒胃方对幽门螺旋杆菌感染小鼠体内NO和胃组织iNOS表达的影响[J].世界华人消化杂志,2015,23(5):711-718. 被引量：6
-
4范玉丽,盛净,朱健,陆平.L-精氨酸对大鼠脂多糖致急性肺损伤的影响及机理[J].临床与病理杂志,2015,35(4):642-647. 被引量：3
-
5邹大进.手术缓解糖尿病宜忌谈[J].家庭用药,2012(11):18-19.
-
6任爱霞,刘洪玥,张峰.人性化护理在糖尿病护理中的应用[J].中国伤残医学,2014,22(14):272-273. 被引量：6
-
7王静,常保超.1,25-二羟维生素D3联合厄贝沙坦治疗糖尿病肾病的临床观察[J].国际泌尿系统杂志,2014,34(1):58-60. 被引量：10
-
8张景岳,安洪泽,槐青梅,王丽.疏血通联合黄芪注射液治疗糖尿病周围神经病变36例[J].实用中西医结合临床,2011,11(1):17-18. 被引量：7
-
9潘晓燕,龚小花,郑景晨,沈飞霞.α-硫辛酸治疗糖尿病周围神经病变的疗效和安全性[J].温州医学院学报,2009,39(5):490-491. 被引量：3
-
10魏静.前列地尔在糖尿病慢性并发症中的应用[J].中国卫生产业,2013,10(33):106-106. 被引量：3
